Elderly African-American man smiling

Why V-Go®?

How your body releases insulin

It may be easier to understand the importance of insulin therapy if you understand how insulin normally works in the body and what happens when you have diabetes.

The main job of insulin is to control sugar in your bloodstream and keep it within a normal range. To do this, your body naturally produces insulin, which is released in small amounts over the course of the day. At mealtimes, your pancreas releases a larger amount of insulin to help manage the sugar from the food you just ate.

However, if you have Type 2 diabetes, your body may not release a sufficient amount of insulin during the day or at mealtimes, which can result in your blood sugar being too high.1 Left untreated, high blood sugar can lead to complications such as blindness, nerve damage (neuropathy) and kidney damage.2

V-Go delivery chart

How V-Go delivers insulin

V-Go is designed to fit easily into your life while delivering insulin much like your body is supposed to*—providing a steady rate of insulin 24 hours a day (basal) and enabling you to give yourself a dose of insulin during mealtimes (bolus).3 And V-Go is discreet, so nobody will know you’re even wearing it.4

*If you follow the V-Go Instructions for Patient Use.

 

Eliminate the need for multiple daily injections5,6

V-Go helps you control your blood sugar day and night with just 1 application, 1 insulin, and simple clicks to deliver mealtime insulin.

28 injections per week

V-Go is a simple insulin delivery device designed for life on the go

  • Easy to use4
  • Convenient3
  • Comfortable4
  • Discreet4,6
  • Wearable3
  • Disposable3
References: 1. Polonsky KS, Given BD, Hirsch LJ, et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988;318(19):1231-1239. 2. American Diabetes Association. http://www.diabetes.org/living-with-diabetes/complications/. Accessed October 3, 2016. 3. V-Go® Instructions for Patient Use. Valeritas Inc. 2011. 4. Rosenfeld CR, Bohannon NJ, Bode B, et al. The V-Go insulin delivery device used in clinical practice: patient perception and retrospective analysis of glycemic control. Endocr Pract. 2012;18(5):660-667. 5. Lajara R, Nikkel C. Poster: Use of V-Go® insulin delivery device in patients with sub-optimally controlled diabetes mellitus: a retrospective analysis from a large specialized diabetes system. Presented at: AACE. May 2015. 6. Lajara R, Fetchik DA, Morris TL, Nikkel C. Use of V-Go® insulin delivery device in patients with sub-optimally controlled diabetes mellitus: a retrospective analysis from a large specialized diabetes system. Diabetes Ther. 2015;6(4);531-545.

Important Risk Information
If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Disposable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.